Overview
This single vial combines BPC-157, a synthetic pentadecapeptide, and TB-500, a synthetic peptide related to thymosin beta-4. The label split of 5/5 indicates 5 mg of each peptide.
Research context
The two peptides are associated with different mechanisms, growth factor signalling in the case of BPC-157 and actin regulation and cell migration in the case of TB-500. The combination is used in preclinical tissue models that examine these pathways together.
Specifications
- Form: Lyophilized powder
- Quantity: 10 mg total (5 mg BPC-157, 5 mg TB-500)
- Composition: BPC-157 5 mg / TB-500 5 mg
- Container: 3 mL glass vial, sealed
- Storage: Minus 20 °C, dry and protected from light
- Documentation: Lot-specific Certificate of Analysis (identity and purity by HPLC-MS), matched to the batch number on the label
For laboratory research use only. Not a drug, food, cosmetic or medical device. Not for human or animal use of any kind. No information on this page is medical advice or dosing guidance.


